uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Lympreva
Refused
Human
Orphan medicine
Details
EMA number
EMEA/H/C/002772
ATC code
L03AX
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of non-Hodgkins lymphoma (FL)
MeSH:
Lymphoma, Non-Hodgkin
Active substances
dasiprotimut-t
Marketing Authorisation Holder
Biovest Europe Ltd
MAH
Lympreva | uMedical